PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Axela’s dotLab™ System Recognized as Most Innovative Protein Assay Platform by Frost & Sullivan - Frost & Sullivan selected Axela Biosensors, Inc. as the recipient of the 2007 Frost & Sullivan Product Innovation Award in the North American protein assays market for its dotLab System
Axela’s dotLab™ System Recognized as Most Innovative Protein Assay Platform by Frost & Sullivan

 

NewswireToday - /newswire/ - Palo Alto, CA, United States, 2007/02/27 - Frost & Sullivan selected Axela Biosensors, Inc. as the recipient of the 2007 Frost & Sullivan Product Innovation Award in the North American protein assays market for its dotLab System.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

This device offers an accessible platform for scientists to determine protein levels and characterize protein interactions. The depth of information provided accelerates immunoassay development and contributes at each stage of the development process, including reagent characterization, antibody pairing, and cross reactivity studies. The platform is unique in its ability to execute both assay development and routine analysis on the same system.

Axela’s dotLab System employs two technologies: grating-based light diffraction and immobilized capture surfaces, the combination of which produces a sensitive and simple technique for detecting molecular binding events without the use of fluorescent labels. In this system, protein-specific capture molecules are immobilized on the dotLab Sensor surface in eight different locations, or assay spots. The capture molecules in each spot are attached to the surface of the sensor in a series of parallel lines, which produce a specific diffraction pattern when illuminated with a laser. The sensor surface forms the base of a low-volume flow cell. When a continuous stream of a sample is introduced, target molecules bind to assay spots, producing an enhanced diffraction signal. The dotLab System then uses the intensity of the diffraction signal to generate real-time binding curves. This combination of independent multiplex detection with a flow-based sensor overcomes many of the challenges faced by end point measurement assays0

"The dotLab Sensor surfaces utilize Avidin, Protein G, goat anti-mouse-Fc and amine-reactive surfaces, enabling quantitative measurement across a broad dynamic range, including high and low abundance proteins in a single sample," says Frost & Sullivan Research Analyst Pramodh Ishwarakrishnan. "Since the illumination and detection beams never pass through the sample, the dotLab System is ideal for the detection of proteins in complex biological samples such as serum, plasma, and crude cell lysates."

The dotLab System represents a novel biosensor platform that enables bench-top researchers to rapidly detect biomarkers in complex media and better understand molecular interactions in real-time. The system cost-effectively helps transform discoveries into assays that can be used by scientists involved in drug discovery, biomarker validation, or translational research. Axela’s recent licensing of A2® Universal Linker Technology from Beckman Coulter will allow users to directly multiplex their own targets, or combine with the Axela library to form custom panels on demand.

"The dotLab System’s biosensor technology allows researchers to rapidly identify and quantify therapeutic and clinically relevant protein biomarkers without the use of a fluorescent tag and detect and understand molecular interactions as they occur," notes Ishwarakrishnan. "The company is presently expanding its library of proprietary biomarker content for multiplexed research or diagnostic assays and is particularly focusing on proteins that have long-term utility in point-of-use settings."

Each year Frost & Sullivan presents this Award to the company that has demonstrated excellence in new products and technologies within their industry. The recipient company has shown innovation by launching a broad line of emerging products and technologies.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Axela Biosensors, Inc., Canada

Axela Biosensors is commercializing products that accelerate the validation of protein biomarkers from discovery into routine clinical practice. The Company has developed a proprietary breakthrough technology, Diffractive Optics Technology (dot™), which enables the real-time detection and quantitation of protein binding events in complex media. Axela has developed this technology into the dotLab™ System, a commercially available bench-top laboratory system that delivers simple, affordable, yet highly sensitive protein based assays. To leverage the opportunities that dot™ creates, Axela has assembled a management team with extensive experience in diagnostic and research product development and commercialization. Axela Biosensors is a privately-held company based in Toronto, Canada whose major investor is VenGrowth Private Equity Partners Inc., one of Canada's premier private equity managers.

About Frost & Sullivan

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Axela’s dotLab™ System Recognized as Most Innovative Protein Assay Platform by Frost & Sullivan

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Stacie Jones 
210.247.2450 Stacie.jones[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Neuronix Ltd Announces the First Group of Mild to Moderate Alzheimer Patients to be Successfully Treated by The NeuroAD™ Therapy System
SelectMDx to be Distributed Across Middle East by IPS Genomix
GE Healthcare Partners with Oritain to Introduce Independent Test to Confirm Country of Origin of Fetal Bovine Serum
Saebo, Inc. Awarded Patent for Low-Profile Stroke Recovery Glove
GE Healthcare and HeartFlow Announce Global Cardiovascular Collaboration
Insulin Delivery Devices Market Size to Expand at 7% CAGR through 2020 Says PMR
Intubation Market Significant Profits Estimated to be Generated by 2025 Says Persistence Market Research
PMR Releases Report for Next Generation IV Infusion Pumps Market Impact of Existing and Emerging Market 2017-2025
Medical Tapes Market to Reach US$ 2Bn by 2024 Reports PMR
Global Pyrogen Testing Market Value Expected to Increase to US$ 1.37 Billion by 2024 Says PMR
Huber Needles Market Expected to Reach US$ 55M by 2024 According to PMR
ZOLL Technologies for Improving CPR Quality to be Showcased at NTI 2017
ConfirmMDx Improves Prostate Cancer Diagnosis in African American Men
Biomarker-based Technologies to Disrupt Conventional Diagnosis in Diabetes Management across the Globe Finds Frost & Sullivan
Agfa Specialty Products Announces the Launch of UNIQOAT

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow Ltd

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)